AIM ImmunoTech Inc is trading 14.6% up at $0.47 in pre-market sessions. - The company announced today, June 15, 2026, that it has regained compliance with NYSE American's continued listing standards related to stockholders' equity, providing a company-specific catalyst for the stock's movement. - This rebound follows its previous close of $0.41 on June 12, 2026, which followed an 11.5% decline.